Lianshen Fengxin Decoction in treatment of excessive salivation and frequent urination overnight in patients with motor neuron disease: An open randomized controlled trial

GAO Penglin, LIAO Weilong, SUN Chuanhe, JIANG Wenfei, PAN Weidong

Journal of Neurology and Neurorehabilitation ›› 2017, Vol. 13 ›› Issue (1) : 10-16.

PDF(2237 KB)
PDF(2237 KB)
Journal of Neurology and Neurorehabilitation ›› 2017, Vol. 13 ›› Issue (1) : 10-16. DOI: 10.12022/jnnr.2016-0068
Original Research

Lianshen Fengxin Decoction in treatment of excessive salivation and frequent urination overnight in patients with motor neuron disease: An open randomized controlled trial

  • GAO Penglin, LIAO Weilong, SUN Chuanhe, JIANG Wenfei, PAN Weidong
Author information +
History +

Abstract

Objective: To investigate the efficacy of Lianshen Fengxin Decoction, a formula of Traditional Chinese Medicine, in treatment of excessive salivation and frequent urination overnight in patients with motor neuron disease (MND). Methods: Fifty-two eligible patients with MND suffering with excessive salivation and frequent urination overnight who were outpatients or inpatients from Department of Neurology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine between June, 2014 and November, 2016 were recruited in this study. The patients were randomly divided into two groups: Lianshen Fengxin Decoction group (n = 26, receiving routine Western medicine in combination with Lianshen Fengxin Decoction for 6 weeks) and routine Western medicine group (n = 26, only receiving routine Western medicine for 6 weeks). The overnight activity, quantity of salivation (24 h) and frequency of urination overnight as the primary measurements, and the score of Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) as the secondary mesurement were used to evaluate the clinical efficacy of Lianshen Fengxin Decoction. Results: There were no significant differences in overnight activity, quantity of salivation (24 h), frequency of urination overnight and ALSFRS score before treatment between two groups (all P > 0.05). At the end of 6-week treatment, there were 4 patients and 5 patients dropped out or lost to follow-up in Lianshen Fengxin Decoction group and routine Western medicine group, respectively. The overnight activity, quantity of salivation (24 h) and the frequency of urination overnight were significantly decreased after treatment as compared with those before treatment in Lianshen Fengxin Decoction group (all P < 0.05), but there were no significant changes observed in routine Western medicine group (all P > 0.05). The ALSFRS score in two groups had no significant changes after treatment (both P > 0.05). No obvious liver and renal dysfunctions were observed in two groups. Conclusion: Traditional Chinese Medicine formula—Lianshen Fengxin Decoction, which has the function of tonifying the kidney and the astringent effect, can obviously decrease the quantity of salivation and frequency of urination overnight in patients with MND.

Key words

Motor neuron disease / Amyotrophic lateral sclerosis / Sialorrhea / Nocturia / Lianshen Fengxin Decoction / Actigraphy

Cite this article

Download Citations
GAO Penglin, LIAO Weilong, SUN Chuanhe, JIANG Wenfei, PAN Weidong. Lianshen Fengxin Decoction in treatment of excessive salivation and frequent urination overnight in patients with motor neuron disease: An open randomized controlled trial[J]. Journal of Neurology and Neurorehabilitation. 2017, 13(1): 10-16 https://doi.org/10.12022/jnnr.2016-0068

References

[1] Gizzi M, DiRocco A, Sivak M, et al. Ocular motor function in motor neuron disease[J]. Neurology, 1992, 42(5):1037-1046.
[2] Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis[J]. Lancet, 2007, 369(9578):2031-2041.
[3] 潘卫东, 苏小静, 王 骏, 等. 健脾益气法治疗肌萎缩侧索硬化症的随机开放临床试验[J]. 上海中医药大学学报, 2013, 27(3):38-41.
[4] 蒋雨平. 运动神经元病[J]. 中国临床神经科学, 2014, 22(6):663-665.
[5] 孙 燕, 潘卫东, 马 骥, 等. 加速度记录仪定量化评价运动障碍性疾病[J]. 中华神经科杂志, 2011, 44:(11)763-767.
[6] 刘 云, 潘卫东, 方正龙, 等. 加速度记录仪定量化评价安神健脑方对早期帕金森患者睡眠障碍的疗效[J]. 神经病学与神经康复学杂志, 2010, 7(3):127-131.
[7] 潘卫东, Kwak S, Hideyama T, 等. 在未编辑的谷氨酸受体2Q/R部位促使RNA2的次黄嘌呤腺苷脱氨酶丢失引起运动神经元的缓慢死亡[J]. 中国临床神经科学, 2013, 21(1):1-11.
[8] 党翠娇, 姜文斐, 孙传河, 等. 散发性肌萎缩侧索硬化发病机制探讨:谷氨酸受体2Q/R部位RNA无效编辑和病理性TDP-43[J]. 神经病学与神经康复学杂志, 2016, 12(2):94-101.
[9] 潘卫东. 结合医学与中西医结合神经病学[J]. 神经病学与神经康复学杂志, 2016, 12(1):8-11.
[10] 潘卫东. 基于个体化治疗的神经病学精准医疗与辨证论治[J]. 神经病学与神经康复学杂志, 2016, 12(2):57-63.
[11] 潘卫东, Kwak S, 吴春岚, 等. 加味四君子汤对肌萎缩侧索硬化症AR2小鼠运动功能的影响[J]. 上海中医药大学学报, 2013, 27(1):60-63.
[12] 眭淑彦. 肌萎缩侧索硬化症的中医病因病机探究[J]. 神经病学与神经康复学杂志, 2014, 10(3):130-132.
[13] 李超生, 胡玲玲, 孔 亮, 等. 复元生肌颗粒对肌萎缩侧索硬化症患者短期预后的疗效[J]. 神经病学与神经康复学杂志, 2011, 7(2):61-64.

Funding

General Project of National Natural Science Foundation of China (No. 81373619)
PDF(2237 KB)

Accesses

Citation

Detail

Sections
Recommended

/